The analysis revealed that AJUBA expression was significantly higher in various tumors than in the respective normal tissues, including bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), CHOL, COAD, lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), ESCA, GBM, HNSC, brain LGG, LIHC, lung squamous cell carcinoma (LUSC), PAAD, READ, and STAD as well as thyroid carcinoma and THYM. This evidence concerns the gene AJUBA and squamous cell lung carcinoma.